KEVATRIL Side Effects

6988225-2 | Interstitial Lung Disease, Pulmonary Sepsis
on Sep 09, 2010 Male patient from GERMANY , weighting 187.8 lb, was diagnosed with antiemetic supportive care, chronic lymphocytic leukaemia and was treated with Kevatril (View Usage). Patient experienced the following unwanted or unexpected effects: interstitial lung disease, pulmonary sepsis. Kevatril dosage: . During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), BENDAMUSTINE (View Bendamustine Review and Bendamustine Label ), PREDNISOLON (View Prednisolon Review and Prednisolon Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), VERGENTAN (View Vergentan Review and Vergentan Label ), CLEMASTINE FUMARATE (View Clemastine Fumarate Review and Clemastine Fumarate Label ), RANITIDINE HCL (View Ranitidine Hcl Review and Ranitidine Hcl Label ). Patient was hospitalized.

6933902-2 | Biliary Colic
Patient was taking Kevatril (View Usage). Patient had the following side effects: biliary colic on Aug 11, 2010 from UNITED STATES Additional patient health information: Male patient , 72 years of age, weighting 275.6 lb, . Kevatril dosage: . During the same period patient was treated with BEVACIZUMAB (Unit Dose) (View Bevacizumab Review and Bevacizumab Label ), IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ), FLUOROURACIL (Bolus Dose.) (View Fluorouracil Review and Fluorouracil Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ATROPIN (View Atropin Review and Atropin Label ). Patient was hospitalized.

6921096-9 | Biliary Colic
Adverse event was reported on Aug 02, 2010 by a Male patient taking Kevatril (View Usage) (Dosage: ) . Location: GERMANY , 72 years of age, weighting 275.6 lb, After Kevatril was administered, patient had the following side effects: biliary colic. During the same period patient was treated with BEVACIZUMAB (Unit Dose) (View Bevacizumab Review and Bevacizumab Label ), IRINOTECAN HCL (Unit Dose) (View Irinotecan Hcl Review and Irinotecan Hcl Label ), FLUOROURACIL (Bolus Dose.) (View Fluorouracil Review and Fluorouracil Label ), FOLINIC ACID (Unit Dose) (View Folinic Acid Review and Folinic Acid Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), ATROPIN (View Atropin Review and Atropin Label ). Patient was hospitalized.

6756340-4 | Chills, Haematuria, Nausea
on May 31, 2010 Male patient from GERMANY , 65 years of age, weighting 132.3 lb, was treated with Kevatril (View Usage). Patient experienced the following unwanted or unexpected effects: chills, haematuria, nausea (What is nausea?). Kevatril dosage: Dose Form: Ampoule. During the same period patient was treated with RITUXIMAB (View Rituximab Review and Rituximab Label ), RANITIDINE (Dose Form: Ampoule) (View Ranitidine Review and Ranitidine Label ), CLEMASTINE FUMARATE (Dose Form: Ampoule) (View Clemastine Fumarate Review and Clemastine Fumarate Label ), BENDAMUSTINE (View Bendamustine Review and Bendamustine Label ), PREDNISOLONE SODIUM SUCCINATE INJ (View Prednisolone Sodium Succinate Inj Review and Prednisolone Sodium Succinate Inj Label ). Patient was hospitalized.


5399335-8 | Syncope
on Jul 18, 2007 Female patient from GERMANY , 52 years of age, weighting 211.6 lb, was diagnosed with antiemetic supportive care, breast cancer (What is breast cancer?) and was treated with Kevatril (View Usage). Patient had the following side effects: syncope. Kevatril dosage: . During the same period patient was treated with DOCETAXEL (Given On Day One Every 21 Days. Form Reported As Infusion.) (View Docetaxel Review and Docetaxel Label ), EPIRUBICIN (Given For Four Cycles.) (View Epirubicin Review and Epirubicin Label ), CYCLOPHOSPHAMIDE (Given For Four Cycles.) (View Cyclophosphamide Review and Cyclophosphamide Label ), ENAHEXAL COMP (Total Daily Dose Reported As 10/25 Mg.) (View Enahexal Comp Review and Enahexal Comp Label ), METOHEXAL RETARD (View Metohexal Retard Review and Metohexal Retard Label ). Patient was hospitalized.

5369217-6 | Asthenia, White Blood Cell Count Decreased
Patient was taking Kevatril (View Usage). After Kevatril was administered, patient had the following side effects: asthenia, white blood cell count decreased on Jun 13, 2007 from GERMANY Additional patient health information: Female patient , 74 years of age, weighting 121.3 lb, . Kevatril dosage: . During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), ONCOFOLIC (View Oncofolic Review and Oncofolic Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

5334827-9 | Pacemaker Complication
Adverse event was reported on May 14, 2007 by a Male patient taking Kevatril (View Usage) (Dosage: ) was diagnosed with antiemetic supportive care, colorectal cancer (What is colorectal cancer?), unevaluable event and. Location: GERMANY , 63 years of age, weighting 176.4 lb, Patient experienced the following unwanted or unexpected effects: pacemaker complication. During the same period patient was treated with BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ), CAMPTOSAR (View Camptosar Review and Camptosar Label ). Patient was hospitalized.

5334778-X | Asthenia, White Blood Cell Count Decreased
on May 15, 2007 Female patient from GERMANY , 74 years of age, weighting 121.3 lb, was treated with Kevatril (View Usage). Patient had the following side effects: asthenia, white blood cell count decreased. Kevatril dosage: . During the same period patient was treated with IRINOTECAN HCL (View Irinotecan Hcl Review and Irinotecan Hcl Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), ONCOFOLIC (View Oncofolic Review and Oncofolic Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

5322224-1 | Circulatory Collapse, Nausea
on May 02, 2007 Female patient from GERMANY , 62 years of age, weighting 187.4 lb, was diagnosed with breast cancer (What is breast cancer?) and was treated with Kevatril (View Usage). After Kevatril was administered, patient had the following side effects: circulatory collapse, nausea (What is nausea?). Kevatril dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), MESNA (View Mesna Review and Mesna Label ), FORTECORTIN (View Fortecortin Review and Fortecortin Label ). Patient was hospitalized.

5234367-1 | Thrombosis
Patient was taking Kevatril (View Usage). Patient experienced the following unwanted or unexpected effects: thrombosis on Jan 29, 2007 from GERMANY Additional patient health information: Female patient , 71 years of age, weighting 187.4 lb, . Kevatril dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ).

5213050-2 | Thrombosis
Adverse event was reported on Jan 10, 2007 by a Female patient taking Kevatril (View Usage) (Dosage: ) . Location: GERMANY , 71 years of age, weighting 187.4 lb, Patient had the following side effects: thrombosis. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ).

5202162-5 | Syncope
on Jan 02, 2007 Female patient from GERMANY , 52 years of age, weighting 211.6 lb, was diagnosed with antiemetic supportive care, breast cancer (What is breast cancer?) and was treated with Kevatril (View Usage). After Kevatril was administered, patient had the following side effects: syncope. Kevatril dosage: . During the same period patient was treated with DOCETAXEL (Frequency Reported As ^d1 Q D21^, Form Reoprted As Infusion.) (View Docetaxel Review and Docetaxel Label ), ENAHEXAL COMP (Total Daily Dose Reorted As 10/25mg) (View Enahexal Comp Review and Enahexal Comp Label ), METOHEXAL RETARD (View Metohexal Retard Review and Metohexal Retard Label ). Patient was hospitalized.

5196933-1 | Neutropenia
on Dec 29, 2006 Female patient from GERMANY , 72 years of age, weighting 157.9 lb, was diagnosed with nausea (What is nausea?) and was treated with Kevatril (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia. Kevatril dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ). Patient was hospitalized.

5192241-3 | Pulmonary Fibrosis
Patient was taking Kevatril (View Usage). Patient had the following side effects: pulmonary fibrosis (What is pulmonary fibrosis?) on Dec 20, 2006 from GERMANY Additional patient health information: Female patient , 74 years of age, weighting 160.9 lb, . Kevatril dosage: . During the same period patient was treated with IRINOTECAN (View Irinotecan Review and Irinotecan Label ), TRENANTONE (Route Was Reported As 3 Months Depot Syringe.) (View Trenantone Review and Trenantone Label ), CASODEX (View Casodex Review and Casodex Label ), OXALIPLATIN (Reported As Strength Was 135 Mg.) (View Oxaliplatin Review and Oxaliplatin Label ), FOLINIC ACID (View Folinic Acid Review and Folinic Acid Label ), FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ).

5099662-8 | Thrombophlebitis, Thrombosis
Adverse event was reported on Jun 22, 2006 by a Female patient taking Kevatril (View Usage) (Dosage: ) . Location: GERMANY , 71 years of age, weighting 187.4 lb, After Kevatril was administered, patient had the following side effects: thrombophlebitis, thrombosis. During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ).

5058078-0 | Thrombosis
on Jun 22, 2006 Female patient from GERMANY , 71 years of age, weighting 187.4 lb, was treated with Kevatril (View Usage). Patient experienced the following unwanted or unexpected effects: thrombosis. Kevatril dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ).

5058065-2 | Thrombophlebitis, Thrombosis
on Jun 22, 2006 Female patient from GERMANY , 71 years of age, weighting 187.4 lb, was treated with Kevatril (View Usage). Patient had the following side effects: thrombophlebitis, thrombosis. Kevatril dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ).

5041096-6 | Thrombosis
Patient was taking Kevatril (View Usage). After Kevatril was administered, patient had the following side effects: thrombosis on Jun 22, 2006 from GERMANY Additional patient health information: Female patient , 71 years of age, . Kevatril dosage: .

4968097-8 | Pulmonary Embolism
Adverse event was reported on Feb 02, 2006 by a Female patient taking Kevatril (View Usage) (Dosage: ) . Location: GERMANY , 63 years of age, weighting 165.3 lb, Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ). Patient was hospitalized.

4910936-0 | Pulmonary Embolism
on Feb 02, 2006 Female patient from GERMANY , 64 years of age, weighting 165.3 lb, was treated with Kevatril (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Kevatril dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ). Patient was hospitalized.

4902202-4 | Haematocrit Decreased, Haemoglobin Decreased, Pancytopenia
on Dec 22, 2005 Female patient from GERMANY , 67 years of age, weighting 180.8 lb, was diagnosed with antiemetic supportive care and was treated with Kevatril (View Usage). After Kevatril was administered, patient had the following side effects: haematocrit decreased, haemoglobin decreased, pancytopenia. Kevatril dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), METHOTREXATE (Day 1 + 8) (View Methotrexate Review and Methotrexate Label ). Patient was hospitalized.

4871974-X | Neutropenia
Patient was taking Kevatril (View Usage). Patient experienced the following unwanted or unexpected effects: neutropenia on Dec 22, 2005 from GERMANY Additional patient health information: Female patient , 67 years of age, weighting 180.8 lb, was diagnosed with antiemetic supportive care and. Kevatril dosage: . During the same period patient was treated with FLUOROURACIL (View Fluorouracil Review and Fluorouracil Label ), CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), EPIRUBICIN (View Epirubicin Review and Epirubicin Label ). Patient was hospitalized.